Lai Elisa Y, Ackermann Lutz, Johansson Magnus J
Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), Biopharmaceuticals R&D, AstraZeneca, Gothenburg Pepparedsleden 1 431 50 Mölndal Sweden
Institut für Organische und Biomolekulare Chemie, Wöhler Research Institute for Sustainable Chemistry (WISCh), Georg-August-Universität Göttingen Tammannstraße 2 37077 Göttingen Germany
Chem Sci. 2025 Apr 10;16(19):8478-8486. doi: 10.1039/d5sc01367d. eCollection 2025 May 14.
Matched molecular series (MMS) are series of molecules that differ only by a single modification at a specific site. The synthesis of MMS is a desirable strategy in drug discovery campaigns. Small aliphatic motifs, notably methyl, mono-, di- and trifluoromethyl substituents (C units), are known to have profound effects on the physiochemical properties and/or potency of drug candidates. In this context, we herein report a unique strategy for achieving direct -selective methylation, mono-, di-, and trifluoromethylation from the same parent compound. This approach takes advantage of a highly -selective ruthenium(ii)-catalyzed alkylation, followed by a subsequent photocatalyzed protodecarboxylation or silver-mediated fluorodecarboxylation to reveal the (fluoro)methyl moiety. This method enables the late-stage access to MMS in small molecules bearing a variety of orienting groups as well as bio-relevant molecules containing complex functionalities, bypassing the need for synthesis to access individual compounds in a series. Moreover, key physiochemical properties of drug candidates were successfully modulated, highlighting opportunities to accelerate medicinal chemistry programs in a sustainable fashion.
匹配分子系列(MMS)是指仅在特定位点存在单一修饰差异的分子系列。MMS的合成是药物发现活动中一种理想的策略。已知小的脂肪族基团,特别是甲基、单氟、二氟和三氟甲基取代基(C单元),会对药物候选物的物理化学性质和/或效力产生深远影响。在此背景下,我们在此报告一种独特的策略,可从同一母体化合物实现直接选择性甲基化、单氟、二氟和三氟甲基化。该方法利用了高度选择性的钌(II)催化烷基化反应,随后进行光催化的原脱羧反应或银介导的氟脱羧反应,以揭示(氟)甲基部分。这种方法能够在带有各种导向基团的小分子以及含有复杂官能团的生物相关分子中实现后期获得MMS,无需合成来获取系列中的各个化合物。此外,成功调节了药物候选物的关键物理化学性质,凸显了以可持续方式加速药物化学项目的机会。